Skip to content

Adipotide vs Semaglutide

Updated 6 sources

Key differences

  1. 1Semaglutide is an approved GLP-1 drug that cuts appetite and has large human trials. Adipotide kills the blood vessels of fat tissue and has no human results.
  2. 2Monkeys on adipotide also ate less, so part of its effect may be appetite too.

Side by side

Facts from each record, in the same words as their own pages.
Adipotide and Semaglutide side by side
AdipotideSemaglutide
Category
  • Weight loss
  • GLP-1, Weight loss
Evidence
  • Animal data only
  • Strong human trials
FDA status
  • Not FDA approvedRegulatory
  • FDA approved as Ozempic +2Regulatory
WADA
  • Not confirmed
  • Not prohibited
Half-lifeNot reported
  • About 1 week. It is still present 5 to 7 weeks after the last dose.Regulatory
Routes
  • Subcutaneous injection
  • Subcutaneous injection, Oral
Forms
  • Vial (powder)
Not reported
Reported doses
  • 0.03 to 0.07 mg/kg (subcutaneous injection)
  • 250 to 1,000 mcg (subcutaneous injection)
  • 0.1 to 5 mg (subcutaneous injection)
  • 0.125 to 7.2 mg (subcutaneous injection)
  • 1.5 to 25 mg (oral)
  • 300 to 1,000 mcg (subcutaneous injection)
Most cited frequency
  • Once daily
  • Once weekly; 4 weeks per step, then hold at 2.4 mg
Vial sizes
  • 1 mg, 2 mg, 5 mg, 10 mgCompetitor guide
  • 5 mg, 10 mg, 20 mg, 30 mgVendor guide
Mixed vial keeps
  • Fridge at 2 to 8 °C, protected from light, no freeze-thaw.Competitor guide
  • Keep the mixed vial in the fridge and use it within about 28 days; one guide says 30.Competitor guide
Protocols on file
  • 7
  • 12

Doses shown are what sources report, labelled by origin. Not medical advice.

Read each in full

Sources

6 sources, each checked by date. Record updated Oct 24, 2026. Numbers are restated in our own words and labelled by where they came from.

Community-reported1

  1. Adipotide: community protocols and reportspeptideprotocolwiki.com, via a competitor guide · checked Oct 24, 2026